News and Updates

Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020

Water4all call 2024 pre-annoucement

Published on | 2 months ago

Programmes Agro-Food, Environment Missions

The third Water4all call on the topic “Water and Circular Economy” will be open on the 12th of September 2024.

The relevant subthemes of this call:

  • "Enhancement of water circularity in industries".
  • "Urban water circularity"
  • "Resource recovery and valorization"
  • "Economic, environmental and social implications of water reuse and recovered products"

This call will be launched by the Water4all (Water Security for the Planet) partnership which is co-funded by the European Union within the frame of the Horizon Europe programme and includes a collaboration with VLAIO and FWO to allow more projects to be approved.

For more information, please access the dedicated pages below or contact your NCP. 

https://www.water4all-partnership.eu/joint-activities/water4all-2024-joint-transnational-call-pre-announcement

https://www.vlaio.be/nl/nieuws/water4all-oproep-met-als-thema-water-en-circulaire-economie.

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1484 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.